Alex Rinehart, PhD, explains how the development of a long-acting injectable offers a new preventive option for HIV.
Alex Rinehart, PhD, Director, Global Prevention Strategy, ViiV Healthcare, explains how the development of a long-acting injectable could potentially offer a new preventive option for individuals at risk for HIV.
